SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merge Healthcare Inc.
MRGE 0.00250+78.6%Nov 3 9:52 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: The Ox1/8/2014 9:34:52 AM
  Read Replies (2) of 134
 
  • Merge Healthcare ( MRGE) says it "recently learned through an internal review that a former sales employee in its eClinical business had falsified the existence or amount of certain customer contracts."
  • No restatement of previously reported financial statements is necessary.
  • MRGE is reducing non-GAAP subscription backlog totals for the Merge DNA unit.
  • Here are the revised figures (in thousands): June 30, 2012, $21,936; September 30, 2012, $29,004; December 31, 2012, $29,108; March 31, 2013, $32,270; June 30, 2013, $37,432; September 30, 2013, $41,219.
  • Ultimately, the employee falsified $5.8M worth of contracts in 2012 and $9.4M last year. The (apparent) rationale: "The individual [likely] falsified these contracts in order to achieve sales quotas and receive additional commissions totaling approximately $250K." ( PR)

  • Report TOU ViolationShare This Post
     Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext